CASI Pharmaceuticals
CASI
#11090
Rank
HK$33.44 M
Marketcap
HK$1.63
Share price
0.00%
Change (1 day)
-84.38%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2022 (TTM): -HK$23.33

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$21.73. In 2021 the company made an earnings per share (EPS) of -HK$21.33 an increase over its 2020 EPS that were of -HK$34.28.

EPS history for CASI Pharmaceuticals from 1996 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$23.339.35%
2021-HK$21.33-37.76%
2020-HK$34.28-8.96%
2019-HK$37.6550%
2018-HK$25.1077.78%
2017-HK$14.12-7.42%
2016-HK$15.25-11.63%
2015-HK$17.26-75.56%
2014-HK$70.59309.09%
2013-HK$17.26-72.84%
2012-HK$63.5368.75%
2011-HK$37.65-48.94%
2010-HK$73.73-19.66%
2009-HK$91.77-62.01%
2008-HK$241.57-0%
2007-HK$241.57-62.67%
2006-HK$647.07134.38%
2005-HK$276.09-13.51%
2004-HK$319.22-44.78%
2003-HK$578.05-62.36%
2002-HK$1,536-26.14%
2001-HK$2,079-20.72%
2000-HK$2,62313.43%
1999-HK$2,312150.47%
1998-HK$923.1694.55%
1997-HK$474.5227.91%
1996-HK$370.99